With just 16 new drugs approved in H1 2022, FDA poised for slew of approvals in H2 [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
With just 16 new drugs approved in H1 2022, FDA poised for slew of approvals in H2Jul. 03, 2022 2:00 PM ETBristol-Myers Squibb Company (BMY)BLUENVSAMLXSNYFOLDBGNEBy:Jonathan BlockSA News Editor19 CommentsBet_Noire/iStock via Getty ImagesAlthough the second quarter and first half of 2022 were tough for many companies in the biopharma space, many investors are looking for a turnaround in the second half of the year.A total of16 new therapies were approvedin the first half of the year. Based on recent annual trends, that's a bit paltry given the U.S. FDA approved 50 new treatments in 2021 and 53 in 2020.Several companies are poised for a boost thanks to FDA action (PDUFA) dates that are upcoming.Here are five candidates that the FDA is scheduled to make a decision on in H2 that are the most anticipated -- and could influence the company's stock price.1. Bristol-Myers Squibb and deucravacitinibBristol (NYSE:up 24%As a allosteric tyrosine kinase 2 inhibitor, deucravacitinib is a potential
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]Seeking Alpha
- Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/2/24 - Beat
BMY
Sec Filings
- 4/22/24 - Form DEFA14A
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BMY's page on the SEC website